Target intelligence / Profile preview

Stratum corneum cohesion structures

Molecular classification
Other
01

Overview

Stratum corneum cohesion structures are the specialized intercellular components of the skin's outermost layer that maintain structural integrity and regulate the permeability barrier (Neubert, 2024). These structures primarily comprise corneodesmosomes—modified desmosomes containing proteins such as corneodesmosin (CDSN), desmoglein 1 (DSG1), and desmocollin 1 (DSC1)—and an intercellular lipid matrix rich in ceramides, cholesterol, and free fatty acids (Haftek, 2015). Their biological function is to provide mechanical cohesion between corneocytes while facilitating the orderly process of desquamation through enzymatic degradation by kallikrein-related peptidases, such as KLK5 and KLK7 (Simon et al., 2001). In pathological conditions like psoriasis and ichthyosis, excessive cohesion leads to hyperkeratosis and scaling, whereas in atopic dermatitis, structural defects contribute to barrier failure and inflammation (Haftek, 2015). Therapeutic agents such as keratolytics, including salicylic acid, urea, and alpha-hydroxy acids, target these structures by promoting the breakdown of protein junctions or disrupting the lipid matrix to alleviate scaling (StatPearls, 2023). Conversely, barrier-repair therapies utilize physiological lipids to reinforce these structures and restore skin health (Neubert, 2024).

Other names
CorneodesmosomesIntercellular lipid matrixCorneocyte cohesion structuresSkin barrier cohesion structures
02

Mechanism of action

Keratolysis via chemical or enzymatic degradation of corneodesmosomal proteins and disruption of the intercellular lipid matrix; restoration of barrier function through lipid replenishment (StatPearls, 2023; Neubert, 2024).

03

Biological functions

Cell adhesionBarrier functionDesquamationSkin hydration
04

Disease associations

PsoriasisAtopic dermatitisIchthyosisXerosisAcne
05

Safety considerations

Skin irritationErythemaIncreased photosensitivityBarrier impairment
06

Interacting drugs

Salicylic acid

9 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Corneodesmosin (CDSN) levelsStratum corneum thicknessSkin hydration levels

Beyond the preview

Go deeper on Stratum corneum cohesion structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stratum corneum cohesion structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call